Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Revoglip-M 1000 Tablet SR

Prescription Icon
Prescription Required

Marketer

Zuventus Healthcare Ltd

Salt Composition

Metformin (1000mg) + Teneligliptin (20mg)

Overview Revoglip-M 1000 Tablet SR

Glycipan-XR 1000mg extended-release tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like kidney disease and vision loss, and may lessen the risk of cardiovascular events such as heart attack or stroke. Glycipan-XR 1000mg may be used as a monotherapy or in conjunction with other antidiabetic agents. Optimal results require adherence to a prescribed diet and regular physical activity. Dosage is personalized based on individual health status, blood sugar readings, and other concurrent medications. Taking the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time each day, maximizes therapeutic benefit; discontinuation should only occur under physician guidance. Effective blood sugar control helps prevent future complications. Maintaining the recommended dietary and exercise plan is crucial for successful diabetes management; lifestyle choices are integral to overall control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, and headache. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylurea medications; patients should be educated on its recognition and management. This medication isn't appropriate for all patients. Prior to initiating treatment, inform your physician about any pre-existing kidney, liver, heart, or pancreatic conditions, as well as significant alcohol consumption. Pregnant or breastfeeding individuals require medical consultation before use. Interactions with other medications are possible; therefore, disclose all current medications to your doctor to ensure safety. Alcohol should be limited due to its potential to lower blood glucose. Your doctor will monitor kidney function and blood glucose levels throughout the treatment period.

Primary Ingredients of Revoglip-M 1000 Tablet SR

No text provided to rephrase.

Uses of Revoglip-M 1000 Tablet SR

Managing type 2 diabetes

Major Benefits of Revoglip-M 1000 Tablet SR:

Follow your physician's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consume Revoglip-M 1000 Tablet SR with a meal.

Common Side effects of Revoglip-M 1000 Tablet SR:

  • Nausea
  • Vomiting
  • Headache
  • Hypoglycemia (low blood glucose level)
  • Diarrhea

How to use Revoglip-M 1000 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Revoglip-M 1000 Tablet SR with a meal.

How Revoglip-M 1000 Tablet SR works:

Extended-release Revoglip-M 1000 tablets contain a dual antidiabetic medication formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Revoglip-M 1000 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Revoglip-M 1000 SR tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Revoglip-M 1000mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Revoglip-M 1000 Tablet SR on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Exercise caution when prescribing Revoglip-M 1000 SR tablets to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is advised. Revoglip-M 1000 SR tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Use of Revoglip-M 1000 SR tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Revoglip-M 1000 Tablet SR :

Should you forget to take a Revoglip-M 1000 Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Revoglip-M 1000 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Revoglip-M 1000 Tablet SR

Using Revoglip-M 1000 Tablet SR as directed by your doctor is safe. However, even with correct dosage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar) may occur. Hypoglycemia is more likely if you're also taking insulin or sulfonylurea. Report any persistent issues to your doctor.
Revoglip-M 1000 Tablet SR rarely causes hypoglycemia by itself, but low blood sugar can result from inadequate caloric intake while using it. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Revoglip-M 1000 Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always seek medical advice before taking any other medication.
Revoglip-M 1000 Tablet SR is contraindicated in patients allergic to its components or excipients. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Revoglip-M 1000 Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a rare but serious side effect characterized by elevated blood lactic acid. This risk is higher in patients with kidney disease, older adults, and those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Revoglip-M 1000 Tablet SR and seek immediate medical attention.
Prolonged use of Revoglip-M 1000 Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may result in anemia, nerve damage, tingling or numbness in extremities, weakness, urinary issues, cognitive changes, and balance problems (ataxia). If you experience these symptoms, consult your doctor for B12 level monitoring and potential supplementation.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Revoglip-M 1000 Tablet SR
99
MRP 115
13% off